<p>Listen or watch along as we explore the changes in Vasculitis treatments since our first series in 2020.</p><p>In this episode, podcast host Mel Brooke, BIRDs Patient and Public Engagement Programme talks with Dr Sarah Skeoch, Consultant Rheumatologist at the RNHRD, RUH Bath about new guidelines and changes in ANCAVasculitis.  We learn how, in the past few years, new treatments have arrived, how steroid use has been re-thought and because there is a lot of new information, we’ll focus more specifically on ANCA-associated vasculitis in this episode and how newer medications are helping to reshape care.  </p><p>We are planning to come back and cover Giant Cell Arteritis and other types of Vasculitis in Spring when more new guidelines are due out.</p><p> </p><p>Useful Links:</p><p><a href="https://www.nass.co.uk/" target="_blank" rel="ugc noopener noreferrer">⁠</a> The Voices Study:</p><p><a href="https://www.vasculitisint.com/voices/" target="_blank" rel="ugc noopener noreferrer">https://www.vasculitisint.com/voices/</a></p><p> </p><p>The New Vasculitis Guidelines:</p><p><a href="https://academic.oup.com/rheumatology/article/64/8/4470/8160140" target="_blank" rel="ugc noopener noreferrer">https://academic.oup.com/rheumatology/article/64/8/4470/8160140</a></p><p> </p><p>UK Vasculitis:</p><p><a href="https://www.vasculitis.org.uk/" target="_blank" rel="ugc noopener noreferrer">https://www.vasculitis.org.uk</a></p><p> </p><p>UKIVAS (Registry Study)</p><p><a href="https://ukivas.ndorms.ox.ac.uk/" target="_blank" rel="ugc noopener noreferrer">https://ukivas.ndorms.ox.ac.uk</a></p><p><a href="" target="_blank" rel="ugc noopener noreferrer">⁠Royal National Hospital for Rheumatic Diseases, RUH Bath⁠</a></p><p>Connect further with us:</p><p>Have questions or thoughts about our information Podcast library?  Interested in joining BIRDs patient research panel? </p><p>Email Mel at  [email protected]</p><p>Be sure to subscribe, rate, and review the podcast to help us continue sharing information that matters!</p><p>The Patient and Public Engagement Programme has been supported by hands-off sponsorships from Eli Lilly and Company Limited, UCB and Amgen -all of whom have provided grant funding but who have were not involved in the development, content or editorial control of this podcast, nor the subsequent review and approval of these materials or general running of the patient and public engagement programme.</p><p>We would also like to thank The Arnold Clark Community Fund, The Cumber Family Charitable Trust, Medlock Charitable Trust, The Ray Harris Charitable Trust and The Hospital Saturday Fund.</p><p>Thank you to all our sponsors for helping us to bring you information that supports you and helps to increase your knowledge of rheumatic diseases.</p><p>Please visit the<a href="https://birdbath.org.uk/" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠BIRD website ⁠⁠⁠⁠⁠</a>⁠⁠⁠⁠⁠⁠⁠ to sign up for news.</p>